Scott M. Coiante
Net Worth
Last updated:
What is Scott M. Coiante net worth?
The estimated net worth of Mr. Scott M. Coiante is at least $3,078,650 as of 7 Oct 2019. He owns shares worth $3,950 as insider and has received compensation worth at least $3,074,700 in Aprea Therapeutics, Inc..
What is the salary of Scott M. Coiante?
Mr. Scott M. Coiante salary is $512,450 per year as Senior Vice President, Company Sec. & Chief Financial Officer in Aprea Therapeutics, Inc..
How old is Scott M. Coiante?
Mr. Scott M. Coiante is 58 years old, born in 1967.
What stocks does Scott M. Coiante currently own?
As insider, Mr. Scott M. Coiante owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Aprea Therapeutics, Inc. (APRE) | Senior Vice President, Company Sec. & Chief Financial Officer | 2,500 | $1.58 | $3,950 |
What does Aprea Therapeutics, Inc. do?
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products pipeline also includes ATRN-Backup, an ATR inhibitor; ATRN-W1051 to treat anti-tumor activity; and ATRN-DDRi. Aprea Therapeutics, Inc. is based in Boston, Massachusetts.
Scott M. Coiante insider trading
Aprea Therapeutics key executives
Aprea Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Eyal C. Attar M.D. (54) Senior Vice President & Chief Medical Officer
- Mr. Christian S. Schade (64) Pres, Chief Executive Officer & Chairman
- Mr. Scott M. Coiante (58) Senior Vice President, Company Sec. & Chief Financial Officer